Food City Colby Jack Cheese, 12 oz. package; also sold in random weight sizes (Bashas' brand name) Also sold in 4/13# with Lakeview na...
⚠ Critical Alert — Stop Using Immediately
This product has been flagged with severe risks (listeria). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.
FDA Recall Notice
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1662-2017.
Firm was notified by supplier that cheese supplied to Lakeview from September 1, 2016 through January 27, 2017 is being recalled due to the potential of Listeria monocytogenes. contamination.
Corrective Action (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1662-2017.
Recall terminated by FDA.
✅ What you should do
- Stop using the product if you own it.
- Check the model number, lot code, or sell-by date against the recall notice above.
- Contact Lakeview Cheese Co Llc or the retailer where you bought it for a refund, replacement, or repair.
- For the most current official instructions, visit the FDA recall page.
- If you've been hurt by this product, report the incident to FDA.
Consumer Contact (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1662-2017.
Lakeview Cheese Co Llc
About the U.S. Food and Drug Administration
The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.
Visit FDA.gov →📣 Report a food, supplement, or cosmetic problem to the FDA
If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.
Lakeview Cheese Co Llc Recall FAQ
Lakeview Cheese Co Llc is the subject of a dairy safety report: Food City Colby Jack Cheese, 12 oz. package; also sold in random weight sizes (Bashas' brand name) Also sold in 4/13# with Lakeview na.... The notice was published on February 16, 2017 by the U.S. Food and Drug Administration (FDA). Approximately 355,477 units are potentially affected.